1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Stem Cells Market
2.2. Global Stem Cells Market, By Product, 2023 (US$ Million)
2.3. Global Stem Cells Market, By Application, 2023 (US$ Million)
2.4. Global Stem Cells Market, By Therapy, 2023 (US$ Million)
2.5. Global Stem Cells Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Stem Cells Market: Competitive Analysis
3.1. Market Positioning of Key Stem Cells Market Vendors
3.2. Strategies Adopted by Stem Cells Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Stem Cells Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Stem Cells Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Stem Cells Market: By Product, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Adult Stem Cells
5.3.1.1. Neuronal Stem Cells
5.3.1.2. Hematopoietic Stem Cells
5.3.1.3. Mesenchymal Stem Cells
5.3.1.4. Umbilical Cord Stem Cells
5.3.1.5. Others

6. Stem Cells Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Regenerative Medicine
6.3.2. Neurology
6.3.2.1. Orthopedics
6.3.2.2. Oncology
6.3.2.3. Hematology
6.3.2.4. Cardiovascular Diseases
6.3.2.5. Diabetes
6.3.2.6. Liver Disorders
6.3.2.7. Others
6.3.3. Drug Discovery and Development

7. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Autologous Stem Cell Therapy
7.3.2. Allogeneic Stem Cell Therapy


8. North America Stem Cells Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Stem Cells Market: By Product, 2022-2032, USD (Million)
8.3. Stem Cells Market: By Application, 2022-2032, USD (Million)
8.4. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
8.5.Stem Cells Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
8.5.1.1.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
8.5.1.2.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
8.5.1.3.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)

9. UK and European Union Stem Cells Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.3. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.4. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.Stem Cells Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.1.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.2.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.3.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.4.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.5.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
9.5.1.6.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)

10. Asia Pacific Stem Cells Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.3. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.4. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.Stem Cells Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.1.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.2.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.3.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.4.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.5.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
10.5.1.6.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)

11. Latin America Stem Cells Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Stem Cells Market: By Product, 2022-2032, USD (Million)
11.3. Stem Cells Market: By Application, 2022-2032, USD (Million)
11.4. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
11.5.Stem Cells Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
11.5.1.1.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
11.5.1.2.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
11.5.1.3.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)

12. Middle East and Africa Stem Cells Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Stem Cells Market: By Product, 2022-2032, USD (Million)
12.3. Stem Cells Market: By Application, 2022-2032, USD (Million)
12.4. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
12.5.Stem Cells Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
12.5.1.1.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
12.5.1.2.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Stem Cells Market: By Product, 2022-2032, USD (Million)
12.5.1.3.2. Stem Cells Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Stem Cells Market: By Therapy, 2022-2032, USD (Million)

13. Company Profile
13.1. Advanced Cell Technology, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. BIOTIME, Inc.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. BrainStorm Cell Therapeutics
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Caladrius
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Cellartis AB
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Celgene Corporation
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. CellGenix GmbH
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Gamida Cell
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Genea BioCells
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Lonza
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. PromoCell GmbH
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Pluristem
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. TiGenix
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Waisman Biomanufacturing
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives